Breaks Categories: News

TuesdayJul 27, 2021 10:05 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Partner with Avaria to Bring Award-Winning KaLaya Brand to LATAM Distribution Network

Flora Growth Corp. (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into a non-binding letter of intent (“LOI”) to form a joint venture (“JV”) with Avaria Inc. Canadian-based Avaria is the manufacturer and owner of KaLaya — an award-winning pain cream distributed across Canada. Through the JV, Flora Growth will manage registration, sales and distribution of KaLaya products in Colombia, Mexico, and other LATAM countries, while Avaria will supply finished product. Flora Growth and Avaria will equally divide the profits from the sale of KaLaya products under the JV, increasing the…

Continue Reading

TuesdayJul 27, 2021 9:58 am

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names New Senior VP of Global Sales and Business Development

Green Hygienics (OTCQB: GRYN) has appointed a new senior vice president. David Racz, a seasoned pharmaceutical executive, has been named senior VP of global sales and business development for the innovative, tech-driven company. Racz has garnered extensive experience in the both the pharma and cannabis sectors, having served in global, senior-level positions with well-known pharmaceutical companies including Pfizer, GlaxoSmithKline and Novartis. At Pfizer, he was vice president of sales and human resources, overseeing the largest expansion in Pfizer’s sales force in history. At SmithKline Beecham, he managed more than 4,000 sales, marketing and R&D employees, who were located in 20 countries…

Continue Reading

TuesdayJul 27, 2021 9:55 am

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Shares Insta Message from ELove: ‘Best Thing on the Market’

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, and its flagship product, Hourglass THC+CBD Patchless Patch Topical Cream, has received an Instagram endorsement from Grammy Award-winning writer, producer and director Damien Matthias, known as ELove. ELove has performed and co-produced with LL Cool J, one of Def Jams Records’ first artists. He also played a key role in launching the careers of Tupac Shakur and John Forte of the Fugees and was integrally involved in the pre-internet marketing team of Def Jam Records, one of the most successful independent labels of all time. “Hourglass, the best thing…

Continue Reading

MondayJul 26, 2021 11:55 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Positioned to Benefit from Revised Colombian Regulations, Is Covered by Argus Research Report

Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, has announced that new Colombian regulations allow the company to increase revenue both long and short term. The regulations also enhance the company’s global supply chain of premium brands and products, and expand economics both domestically and abroad. The changes were made when the president of Colombia accepted and signed into effect revisions to existing Colombian cannabis laws. Revisions now allow for the sale and export of raw cannabis materials, including dried flower, to international markets. In addition, Colombian cultivators are now positioned to be leading…

Continue Reading

FridayJul 23, 2021 10:07 am

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Releases Q4, FY 2020 Financial Reports

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has reported fourth quarter and full year 2020 financial results and company highlights. The report noted that Q4 2020 adjusted sales totaled C$28.6 million, an increase of 290% over the third quarter, with fourth quarter 2020 revenue reaching  C$15.7 million, an increase of 158% over the third quarter. Finally, full year 2020 adjusted sales topped more than $37.8 million with revenue coming in at $23.3 million. In addition, the announcement noted that RWB closed two significant acquisitions, completed its go-public transaction and established its…

Continue Reading

ThursdayJul 22, 2021 2:36 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Accelerated Growth for Alkaline88(R)

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, today announced that its bulk three-liter and best-selling one-gallon bottles will be added to five warehouses of Associated Wholesale Grocers (“AWG”), the nation’s largest cooperative food wholesaler to independently owned supermarkets. According to the update, AWG serves over 1,100 member companies and over 3,000 locations throughout 28 states. Alkaline88(R) will be added to AWG’s warehouses in Louisiana, Kansas, Missouri, Oklahoma, and Wisconsin. “The addition of Associated Wholesale Grocers’ (‘AWG’) five strategically located warehouses comes at the perfect time for our company. Our supply chain has…

Continue Reading

ThursdayJul 22, 2021 12:30 pm

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Issues Shareholder Update Outlining Growing Nug Avenue Operations, Strides Toward Vertical Integration

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, today updated current and prospective shareholders on its growing Nug Avenue operations. The update also included progress on the company’s continued strides toward verticalizing its model through the acquisition of California cannabis licenses and potentially establishing commercial operations in the cannabis delivery market outside of the state of California. “We will have more details on Nug Avenue performance soon, but we wanted to report our strong progress and let our shareholders know that we are quickly establishing a brand presence in the Los Angeles cannabis…

Continue Reading

ThursdayJul 22, 2021 11:14 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of Antiviral Drug Studies, Strategy Moving Forward

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has released a summary of its 2021 antiviral drug program so far this year, noting that all objectives in evaluating its proprietary DehydraTECH(TM) drug-delivery platform have been achieved. In addition, the company also discussed next steps. In short, the company stated that it has successfully tested and released summary results on five different compounds from three antiviral drug classes, with results gathered that indicate up to a threefold increase in oral drug delivery into the bloodstream upon animal testing when processed with DehydraTECH. According to the announcement, the company has been able…

Continue Reading

WednesdayJul 21, 2021 12:19 pm

CannabisNewsBreaks – Cannabis Strategic Ventures Inc. (NUGS) Closes Books on Defining, Momentous Year of Material Growth

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced the filing of its 2020 unaudited financial performance data. According to the update, the company closed the books on a momentous year of material growth that featured strong expansion in business activity, as well as robust gains in both top- and bottom-line metrics. “2020 was a defining year for NUGS, as we pushed into a higher gear in terms of commercial activity and market positioning despite the unusual challenges of the global pandemic health crisis,” said Simon Yu, CEO of Cannabis Strategic Ventures. “We were…

Continue Reading

WednesdayJul 21, 2021 11:03 am

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Significantly Enhanced Delivery of Colchicine

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. According to the update, the study demonstrated that DehydraTECH(TM)-enabled colchicine, the latest of several drugs Lexaria has successfully tested with known SARS-CoV-2 antiviral properties, benefited from the company’s proprietary formulation and processing, resulting in significantly increased delivery. The study also examined absorption with two other antiviral drugs previously untested by Lexaria; however, the bloodstream delivery findings were unremarkable and further work is required should the company decide to pursue additional testing with…

Continue Reading